vVardis develops oral care and dental treatment products using biomimetic peptide technology to address tooth decay and enamel repair.
vVardis's investors include OrbiMed, Apollo Funds.
vVardis is headquartered in Baar, Switzerland.
vVardis develops oral care and dental treatment products using biomimetic peptide technology to address tooth decay and enamel repair.
vVardis is at the Private Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"vVardis — Funding & Investors." VCBacked, April 27, 2026, https://www.vcbacked.co/company/vvardis. Accessed September 28, 2026.
VCBacked. (2026). vVardis — Funding & Investors. Retrieved September 28, 2026, from https://www.vcbacked.co/company/vvardis
{{cite web |title=vVardis — Funding & Investors |url=https://www.vcbacked.co/company/vvardis |website=VCBacked |access-date=September 28, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated